Gakken Holdings (9470) Q2 2026 earnings summary

Executive summary

• H1 FY2026 net sales rose 6.1% YoY to ¥104,880 million; EBITDA increased 5.8% to ¥7,037 million and operating profit rose 2.8% to ¥4,670 million.

• Growth reflected DTP consolidation and higher Healthcare and Nursing sales; lower Publishing and Global Business profits partly offset gains in childcare and dementia group homes.

Financial highlights

• Ordinary profit increased 5.7% YoY to ¥4,450 million, supported by operating profit growth and improvement versus prior-year equity-method investment losses.

• Profit attributable to owners of parent fell 14.0% to ¥2,086 million; EPS was ¥50.31 versus ¥58.06, reflecting prior-year extraordinary income and current-period investment-security valuation losses.

• Gross profit rose to ¥28,592 million from ¥26,991 million; operating expenses increased to ¥23,921 million from ¥22,449 million.

Outlook and guidance

• FY2026 forecast unchanged: net sales ¥205,000 million, EBITDA ¥13,500 million, operating profit ¥8,500 million, ordinary profit ¥8,300 million and net income ¥4,000 million.

• FY2027 targets: net sales ¥215.0bn, EBITDA ¥14.5bn, operating profit ¥9.5bn, net profit ¥4.5bn and ROE 8.0%.

• FY2026 annual dividend forecast is ¥29 per share, including ¥14.50 interim, versus ¥26 in FY2025; DOE target is 2.3%.